Log in to your Inderes Free account to see all free content on this page.

Respiratorius

1.64 SEK

+8.28%

Less than 1K followers

RESP

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

+8.28 %
+26.74 %
+24.33 %
+0.93 %
-21.01 %
-63.34 %
-95.51 %
-98.28 %
-88.57 %

Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was established in 1999 as a spin-off from Lund University. The operations are located in Sweden, where research is conducted in-house, but also through international partners. The company has its headquarters in Lund.

Read more
Market cap
12.92M SEK
Turnover
60.05K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26.5.
2026

Interim report Q1'26

9.6.
2026

General meeting '26

11.8.
2026

Interim report Q2'26

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio